{
    "Trade/Device Name(s)": [
        "Quantia A1-AT",
        "Quantia Proteins Control",
        "Quantia Proteins Standard"
    ],
    "Submitter Information": "Biokit S.A.",
    "510(k) Number": "K050596",
    "Predicate Device Reference 510(k) Number(s)": [
        "K860894"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "DEM",
        "JJS",
        "JJX"
    ],
    "Summary Letter Date": "May 13, 2005",
    "Summary Letter Received Date": "March 8, 2005",
    "Submission Date": "February 24, 2005",
    "Regulation Number(s)": [
        "21 CFR 866.5130"
    ],
    "Regulation Name(s)": [
        "Alpha 1-antitrypsin Immunological Test System"
    ],
    "Analyte Class(es)": [
        "immunology"
    ],
    "Analyte(s)": [
        "Alpha-1-antitrypsin"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Plasma"
    ],
    "Specimen Container(s)": [
        "Heparin tube",
        "EDTA tube"
    ],
    "Instrument(s)/Platform(s)": [
        "AEROSET system"
    ],
    "Method(s)/Technology(ies)": [
        "Turbidimetry"
    ],
    "Methodologies": [],
    "Submission Type(s)": [
        "Assay",
        "Control",
        "Standard"
    ],
    "Document Summary": "FDA 510(k) summary for Quantia A1-AT assay, control, and standard for quantitative determination of alpha-1-antitrypsin in serum or plasma using turbidimetry on AEROSET system",
    "Indications for Use Summary": "Intended for in vitro quantitative determination of alpha-1-antitrypsin concentration in human serum or plasma as an aid in the diagnosis of juvenile and adult cirrhosis of the liver and pulmonary emphysema; controls and standards for assay calibration and quality control",
    "fda_folder": "Immunology"
}